Capital Advisors Ltd’s Novartis NVS Stock Holding History

Capital Advisors Ltd’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-84	Closed	-$7K	–	486
2021 Q1	$7K	Hold	84	–	–	﹤0.01%	428
2020 Q4	$8K	Hold	84	–	–	﹤0.01%	396
2020 Q3	$7K	Hold	84	–	–	﹤0.01%	400
2020 Q2	$7K	Hold	84	–	–	﹤0.01%	391
2020 Q1	$7K	Hold	84	–	–	﹤0.01%	392
2019 Q4	$8K	Sell	84 -86	-51%	-$7.72K	﹤0.01%	364
2019 Q3	$15K	Sell	170 -914	-84%	-$82.1K	﹤0.01%	325
2019 Q2	$99K	Buy	1,084 +532	+96%	+$45K	0.03%	211
2019 Q1	$48K	Hold	552	–	–	0.01%	291
2018 Q4	$42K	Hold	552	–	–	0.01%	300
2018 Q3	$43K	Buy	+552	New	+$40.8K	0.01%	320
2015 Q3	–	Sell	-575	Closed	-$51K	–	341
2015 Q2	$51K	Buy	575 +335	+140%	+$30.7K	0.03%	183
2015 Q1	$21K	Hold	240	–	–	0.01%	230
2014 Q4	$20K	Hold	240	–	–	0.01%	225
2014 Q3	$20K	Hold	240	–	–	0.01%	230
2014 Q2	$19K	Hold	240	–	–	0.01%	242
2014 Q1	$18K	Hold	240	–	–	0.01%	244
2013 Q4	$17K	Buy	+240	New	+$16.7K	0.01%	211

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Capital Advisors Ltd's NVS Position: Q2 2021 in Review

Capital Advisors Ltd sold out of Novartis (NVS) in Q2 2021, closing a stake of 84 shares — an estimated $7K sold.

Capital Advisors Ltd first reported a position in NVS in Q4 2013 and held it in 18 quarters. The position peaked at $99K in Q2 2019. 1,120 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

Capital Advisors Ltd reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
Capital Advisors Ltd sold 84 Novartis shares in Q2 2021, an estimated $7K.
Capital Advisors Ltd first reported a position in Novartis in Q4 2013 and held it in 18 quarters.
Capital Advisors Ltd's Novartis position peaked at $99K in Q2 2019.
1,120 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Capital Advisors Ltd's 13F filing for Q2 2021, filed 10 Aug 2021.